摘要
【目的】探讨厄贝沙坦氢氯噻嗪片治疗轻中度高血压病患者的疗效。【方法】将136例轻中度高血压病患者随机分为两组，观察组（68例）服用厄贝沙坦氢氯噻嗪片治疗，对照组（68例）服用厄贝沙坦片治疗，均治疗8周，对比分析两组患者的疗效及不良反应。【结果】观察组总有效率为97．1％，明显高于对照组的77．9％，差异有显著性（P〈0．05），两组患者不良反应发生率相比较差异无显著性（P〉0．05）。【结论】厄贝沙坦氢氯噻嗪片治疗轻中度高血压痛患者具有疗效确切、不良反应发生率低等优点。
[Objective] To explore the clinical efficacy of irbesartan hydrochlorothiazide tablets for the treatment of patients with mild-to-moderate hypertension. [Methods] Totally 136 patients with mild-to-moderate hypertension were divided into 2 groups randomly. The observation group（ n= 68） received irbesartan hydrochlorothiazide tablets, while control group（ n = 68） was given irbesartan hydrochlorothiazide tablets. All patients were treated for 8 weeks. The efficacy and incidence rate of adverse reactions were compared between two groups. [Results] The total effective rate in observation group was 97.1%, which was obviously higher that in control group, and there was significant difference（ P〈0.05）. There was no significantly difference in the incidence rate of adverse reactions between 2 groups（ P〉0. 05）. [Conclusion] Irbesartan hydrochlorothiazide tablets for the treatment of patients with mild-to-moderate hypertension has advantages such as certain efficacy and low incidence rate of adverse reactions.
出处
《医学临床研究》
CAS
2012年第10期1933-1934,共2页
Journal of Clinical Research
